Literature DB >> 7561088

IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide.

P Matthys1, G Froyen, L Verdot, S Huang, H Sobis, J Van Damme, B Vray, M Aguet, A Billiau.   

Abstract

Mice with a disruption of the IFN-gamma receptor alpha-chain gene (IFN-gamma R alpha o/o mice) were found to be significantly more sensitive than their wild-type counterparts to induction of the anti-CD3-induced disease syndrome. Specifically, when given a selected dose of anti-CD3 Ab, IFN-gamma R alpha o/o mice developed severe hypothermia and hypoglycemia, leading to 100% mortality within 72 h. In contrast, wild-type mice failed to develop overt pathologic manifestations and survived. Histologic examination revealed apoptosis in thymuses and spleens, which were significantly more pronounced in the mutant than in the wild-type mice, as confirmed by flow cytometric and DNA electrophoretic analysis. Apoptosis affected mainly CD4+CD8+ and CD4+CD8- thymocytes. Other histologic alterations were steatosis in livers, and erythrocyte extravasation and infiltration of apoptotic cells in lungs, all of which were exclusively observed in IFN-gamma R alpha o/o mice. Blood levels of TNF, IL-2, IL-6, and IL-10 were slightly more elevated in IFN-gamma R alpha o/o mice, but insufficiently so to explain increased disease severity. Thus, even more elevated cytokine levels in wild-type mice receiving high doses of anti-CD3 Ab were not associated with morbidity or apoptosis. Blood levels of IFN-gamma were barely detectable in anti-CD3-challenged wild-type mice, but were relatively high in the mutant mice. Increased susceptibility of IFN-gamma R alpha o/o mice was associated with impaired nitric oxide (NO) production, as indicated by significantly lower plasma nitrite levels and by more transient expression of spleen inducible NO synthase mRNA. Moreover, treatment of wild-type mice with the NO synthase inhibitor N-nitro-L-arginine methylester resulted in increased anti-CD3-induced morbidity and mortality. The data indicate that IFN-gamma R alpha o/o mice produce less NO and are therefore more sensitive than wild-type mice to the deleterious effect of anti-CD3 Ab.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561088

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Induction of IL-15 by TCR/CD3 aggregation depends on IFN-gamma and protects against apoptosis of immature thymocytes in vivo.

Authors:  P Matthys; H Dooms; P Rottiers; T Mitera; L Overgergh; G Leclercq; A Billiau; J Grooten
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

Review 2.  Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts.

Authors:  C M Kokron; F A Bonilla; H C Oettgen; N Ramesh; R S Geha; F Pandolfi
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

3.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes.

Authors:  B Wang; I André; A Gonzalez; J D Katz; M Aguet; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death.

Authors:  A Lerner; L K Clayton; E Mizoguchi; Y Ghendler; W van Ewijk; S Koyasu; A K Bhan; E L Reinherz
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

Review 5.  Biochemical and molecular mechanisms regulating apoptosis.

Authors:  K S Saini; N I Walker
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.842

Review 6.  Regulation of autoimmune inflammation by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Immunol Lett       Date:  2008-08-09       Impact factor: 3.685

7.  Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.

Authors:  Rachel Frawley; Kimber White; Ronnetta Brown; Deborah Musgrove; Nigel Walker; Dori Germolec
Journal:  Environ Health Perspect       Date:  2010-11-01       Impact factor: 9.031

8.  Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.

Authors:  B P Mahon; B J Sheahan; F Griffin; G Murphy; K H Mills
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

9.  IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.

Authors:  Karen Put; Ellen Brisse; Anneleen Avau; Maya Imbrechts; Tania Mitera; Rik Janssens; Paul Proost; Francesca Fallarino; Carine H Wouters; Patrick Matthys
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.